Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127590921 | 12759092 | 1 | I | 20160830 | 20160915 | 20160919 | 20160919 | EXP | GB-JNJFOC-20160915227 | JANSSEN | 41.00 | YR | A | M | Y | 0.00000 | 20160919 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127590921 | 12759092 | 1 | PS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | U | U | 21976 | 800 | MG | TABLETS | ||||||
127590921 | 12759092 | 2 | SS | RALTEGRAVIR POTASSIUM | RALTEGRAVIR POTASSIUM | 1 | Oral | U | 0 | 400 | MG | UNSPECIFIED | |||||||
127590921 | 12759092 | 3 | SS | LAMIVUDINE. | LAMIVUDINE | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
127590921 | 12759092 | 4 | SS | NORVIR | RITONAVIR | 1 | Unknown | U | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127590921 | 12759092 | 1 | Product used for unknown indication |
127590921 | 12759092 | 2 | Product used for unknown indication |
127590921 | 12759092 | 3 | Product used for unknown indication |
127590921 | 12759092 | 4 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127590921 | 12759092 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127590921 | 12759092 | Skin ulcer |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |